United Arab Emirates
Hayat Biotech is a UAE-based global biotechnology company founded in 2021. A joint venture between G42 and Sinopharm CBG, the company aims to combine the expertise and resources of two prominent nations to push the boundaries of science. Their focus spans across four key areas - Human Health, Medical Diagnostics, Cosmetic Aesthetics, and Animal Health.
With its slogan "Your Partner in Science + Life," the company positions itself as a significant player in the Biopharma and Biotechnology industries, demonstrating its commitment to advancing human-centric solutions. Hayat Biotech's dedication to reimagining the future of life reflects in their relentless pursuit of biotechnological advancements with potential global impact.
As the company is new and no specific information about the latest investment or investors is available, Hayat Biotech presents an intriguing opportunity for venture capital firms to potentially engage with a rapidly evolving player in the biotechnology landscape.
